Picture of Clearpoint Neuro logo

CLPT Clearpoint Neuro News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Clearpoint Neuro Inc expected to post a loss of 18 cents a share - Earnings Preview

* Clearpoint Neuro Inc  CLPT.OQ   CLPT.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 11. 
    * The Solana Beach California-based  company is expected to
report
 a 1.5% increase in revenue to $5.105 million from $5.03 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. The company's guidance on March 1 2023,
for the period ended March 31, was for revenue between $5.00
million and $5.50 million.
    * ​Refinitiv's mean analyst estimate for Clearpoint Neuro
Inc is
for a loss of 18 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 11.1%
in the last three months. ​
    * Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $18​, above​ its last closing price of $9.35. ​​​

This summary was machine generated May 10 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Clearpoint Neuro

See all news